Volume 2294
Methods in Molecular Biology
Series Editor
John M. Walker
School of Life and Medical Sciences, University of Hertfordshire, Hatfield, Hertfordshire, UK
For further volumes: http://www.springer.com/series/7651 For over 35 years, biological scientists have come to rely on the research protocols and methodologies in the critically acclaimed Methods in Molecular Biology series. The series was the first to introduce the step-by-step protocols approach that has become the standard in all biomedical protocol publishing. Each protocol is provided in readily-reproducible step-by step fashion, opening with an introductory overview, a list of the materials and reagents needed to complete the experiment, and followed by a detailed procedure that is supported with a helpful notes section offering tips and tricks of the trade as well as troubleshooting advice. These hallmark features were introduced by series editor Dr. John Walker and constitute the key ingredient in each and every volume of the Methods in Molecular Biology series. Tested and trusted, comprehensive and reliable, all protocols from the series are indexed in PubMed.
For over 35 years, biological scientists have come to rely on the research protocols and methodologies in the critically acclaimed Methods in Molecular Biology series. The series was the first to introduce the step-by-step protocols approach that has become the standard in all biomedical protocol publishing. Each protocol is provided in readily-reproducible step-by-step fashion, opening with an introductory overview, a list of the materials and reagents needed to complete the experiment, and followed by a detailed procedure that is supported with a helpful notes section offering tips and tricks of the trade as well as troubleshooting advice. These hallmark features were introduced by series editor Dr. John Walker and constitute the key ingredient in each and every volume of the Methods in Molecular Biology series. Tested and trusted, comprehensive and reliable, all protocols from the series are indexed in PubMed.
Metastasis
Methods and Protocols
1st ed. 2021
Logo of the publisher
Editor
Ulrike S. Stein
Translational Oncology of Solid Tumors Experimental and Clinical Research Center, Charit Universittsmedizin Berlin and Max-Delbrck-Center for Molecular Medicine, Berlin, Germany
ISSN 1064-3745 e-ISSN 1940-6029
Methods in Molecular Biology
ISBN 978-1-0716-1349-8 e-ISBN 978-1-0716-1350-4
https://doi.org/10.1007/978-1-0716-1350-4
Springer Science+Business Media, LLC, part of Springer Nature 2021
This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed.
The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use.
The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, expressed or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This Humana imprint is published by the registered company Springer Science+Business Media, LLC, part of Springer Nature.
The registered company address is: 1 New York Plaza, New York, NY 10004, U.S.A.
Preface
Cancer metastasis is the most lethal attribute of cancer. It is estimated that at least 90% of all cancer patients dying from any type of cancer are dying due to cancer metastasis. Cancer metastasis is both the process and the outcome of the process, whereby cancer cells leave a tumor at the primary or original site, spread throughout the body, and seed tumors in new organs or secondary sites. It is mainly metastasis that makes cancer lethal. Although there is no cure for metastasis, only 5% of cancer research funding worldwide is devoted to metastasis research.
With this book edition we will enable current and future basic and translational researchers, clinical scientists, and oncologists to take the challenges and work in this field of research. This book series is devoted to disseminate Methods and Protocols, with focus on those indispensable for state-of-the-art metastasis research.
The first part introduces models useful for metastasis research, starting with Zebrafish models for cancer cell invasion and metastasis, the chicken egg chorioallantoic membrane (CAM) model for investigating invasion and the metastasis cascade, in vitro 3D models for tunable stiffness, patient-derived mouse xenografted (PDX) metastasis models from solid tumors for predicting therapy response, and organotypic hippocampal slices to analyze brain metastasis and primary brain tumor growth. In the second part, functional in vitro assays are described, illustrating the steps of the metastatic cascade, such as cancer cell mechanical properties, matrix degradation, cancer cell adhesion, migration, and invasion, platelet aggregation, blood-based pro-metastasis immune cells, bone marrow-derived macrophages, and cancer cell extravasation. The third part describes options for prognostication of metastasis, e.g., by using bioinformatics pipelines to identify metastatic biomarkers, barcoding technology and in vivo assessment for analyzing metastatic abilities and metastatic cell potential, as well as nucleolar contents and proteases to uncover metastatic progression. A last, fourth part complements the book outline with clinical methods, such as imaging procedures and the path toward metastasis research from the clinical setting showing a clinicians perspective.
Finally, we would very much appreciate if also the cancer patient her/himselfwho certainly is the center of all effortsmight benefit from this book. Since when the patient is asking Has it spread?, she/he is actually asking: What is my prognosis? Do I have therapy options? Will I survive? The hope is that this book edition will contribute to a more often optimistic answer to the patient.
Ulrike S. Stein
Berlin, Germany
Contents
Part I Metastasis Models
Sarah Martinez Roth , Eric B. Berens , Ghada M. Sharif , Eric Glasgow and Anton Wellstein
Jrg H. Leupold , Nitin Patil and Heike Allgayer
Elysse C. Filipe , Amelia L. Parker , Antonia L. Cadell , Gretel Major , David R. Croucher and Thomas R. Cox
Annika Wulf-Goldenberg , Jens Hoffmann , Michael Becker , Bernadette Brzezicha and Wolfgang Walther